We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Automated Gram Smears Equated to Manual Preparations

By LabMedica International staff writers
Posted on 23 Jul 2013
A comparison has been made of Gram smear preparations for identifying bacteria by both a manual method and a Walk Away Specimen Processor (WASP). More...


It is recommended that 30 µL of ESwab sample is the optimal volume for the preparation of manual or automated Gram smears with representation of all elements important for a clinical outcome.

Microbiologists at the Algemeen Medisch Laboratorium (AML; Antwerp, Belgium) analyzed 300 genital samples submitted to the laboratory for routine investigation. All samples were collected with eSwab (Copan Italia; Brescia, Italy) and two smears were prepared from all collected samples.

One smear was prepared manually, by directly streaking the flocked swab from the eSwab sample collection onto a glass slide and dried at room temperature. The second smear was prepared automatically on the Copan WASP with the extended Gram SlidePrep Module. A protocol for smear preparation had been created on the WASP using the 10-µL loop. Both manual and automated prepared smears were fixed with 95% methanol for one minute, stained using the Elitech Gram reagents and methodology (Wescor Inc.; South Logan, UT, USA) and examined under a light microscope with 10 × 100 magnification.

Smears were semiquantitatively evaluated for the presence of the following elements: Lactobacillus, Gardnerella vaginalis, clue-cells, Mobiluncus species, leucocytes, and epithelial cells. The number of Lactobacillus, G. vaginalis, clue-cells, and Mobiluncus present on each smear was also evaluated using the Nugent score system to diagnose bacterial vaginosis. Manual prepared smears had 78% Lactobacillus, 16.6% G. vaginalis, 4.6% Mobiluncus species, and 13.6% clue-cells, while the WASP prepared smear detected 72%, 16%, 5%, and 15% respectively with 10 µL of eSwab sample.

The authors concluded that Gram smears, prepared with 10 µL of eSwab sample on the WASP, had similar number of microorganisms compared to the manual Gram smear in the presence of leucocytes and epithelial cells. The use of the 10-µL loop instead of the 30 µL on the WASP improved the workflow by avoiding changing the loop while processing the same sample. The study was presented at the American Society of Microbiology annual meeting held May18-21, 2013, in Denver (CO, USA).

Related Links:
Algemeen Medisch Laboratorium
Copan Italia
Wescor Inc.



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
DNA Extraction Kit
MagMAX DNA Multi-Sample Ultra 2.0 Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.